BioSante Pharmaceuticals Report issue

For profit Phase 3
Founded: Lincolnshire IL United States (1996)
Status: Acquired by Ani Pharmaceuticals (2013)

Organization Overview

First Clinical Trial
2003
NCT00391417
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioSante Pharmaceuticals, Inc. | GECEM

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Disease (Phase 3)

Hot Flashes (Phase 3)

Hypokinesia (Phase 3)

Sexual Dysfunctions, Psychological (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 3